Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects

A. Scaife, D. Miller, D. Spiteri-Cornish, T. Steve, G. Devereux, G. Walsh (Aberdeen, United Kingdom)

Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Session: The pulmonary epithelium: recent developments
Session type: Poster Discussion
Number: 3122
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Scaife, D. Miller, D. Spiteri-Cornish, T. Steve, G. Devereux, G. Walsh (Aberdeen, United Kingdom). Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects. Eur Respir J 2013; 42: Suppl. 57, 3122

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhibitors of apoptosis proteins in asthmatic airway inflammation
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013


The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Differential effect of fluticasone on Poly(I:C) induced TSLP secretion by bronchial epithelial cells from asthmatic children
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014

Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013

Tiotropium and olodaterol exert anti-proliferative effects on pulmonary fibroblasts of asthmatic patients in vitro
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015

The effect of a leukotriene antagonist, pranlukast, on allergen-induced airway responses and circulating dendritic cells in subjects with atopic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 414s
Year: 2003

Differential effects of simvastatin and dexamethasone on TLR3-induced anti-viral cytokines in asthmatic epithelium
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013

Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Impairment of leptin/leptin receptor pathway in nasal epithelium from allergic turbinates
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013


Effect of ambroxol and beclomethasone on LPS/TNF-alpha-induced neutrophil-related chemokines and nitrative stress in human bronchial epithelial cells
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013


Formoterol protects against platelet-activating factor-induced effects in asthma
Source: Eur Respir J 2004; 23: 71-75
Year: 2004



Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003

IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013